Finding early memory problems and dementia in different places in Pavia
Compares ways of spotting dementia or mild cognitive impairment early in adults.
Key facts
- Who runs it
- IRCCS National Neurological Institute "C. Mondino" Foundation
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Case-Finding for Neurocognitive Disorders in Pavia
- Status
- Recruiting
- People taking part
- 490 people, planned
- Started
- 11 Jul 2024
- Planned end
- 31 Jul 2026
- Type of study
- Interventional
- Treatments tested
- Case-finding for Neurocognitive Disorders
- Record updated
- 21 May 2025
Who can take part
The trial is looking for people aged 50 or older with no diagnosis of cognitive decline, who take memory tests in Pavia. It also includes patients, family caregivers and health workers in local dementia projects.
- Age
- Memory testing part: 50 or older. Caregivers: 18 or older.
- Sex
- All
- Disease stage
- Memory testing part: no prior diagnosis of cognitive decline. Caregivers look after a family member with suspected or confirmed dementia.
- Main reasons for not taking part
- Memory testing part: under 50
- Memory testing part: already diagnosed with cognitive decline
- Limited knowledge of the Italian language (memory testing part and caregivers)
- Paid caregivers, or caregivers under 18
- Not able to understand the study aims and sign consent
Show the full registry criteria (19)Hide the full registry criteria
Other criteria
- For the Primary Outcome the inclusion criteria are:
- Age 50 or older
- Assessment conducted using GPcog/ACE-III depending on the setting
- No prior diagnosis of cognitive decline
- Ability to understand the study objectives and sign an informed consent; For the Primary Outcome the exclusion criteria are:
- Age under 50
- Presence of a diagnosis of cognitive decline
- Limited knowledge of the Italian language; For the secondary outcome the inclusion criteria are:; Patient:
- All patients/people who are included in one of the actions provided through the "Ricor-Dare" Project or who are attending a visit scheduled in the clinical-care pathway of the CDCD Fondazione Mondino Pavia or Lomellina
- Ability to understand the aims of the study and to sign an informed consent; Caregiver:
- Age equal to or greater than 18 years
- Informal caregiver of a family member with a suspected or confirmed diagnosis of dementia who is included in one of the actions provided through the "Ricor-Dare" project or who are attending a visit scheduled in the clinical-care pathway of the CDCD
- Acceptance of informed consent and voluntary participation in the study; Healthcare professionals:
- All healthcare and social healthcare professionals (GPs, pharmacists, nurses, nurses auxiliary) who practice in the cities of Pavia and Vigevano who participate in the project and agree to undergo assessments and training
- Acceptance of informed consent and voluntary participation in the study; Fo the Secondary Outcome the exclusion criteria are:; Patient:
- Inability to understand the aims of the study and to sign an informed consent; Caregiver:
- Age under 18
- Formal caregivers, i.e. any person who provides assistance to the patient in exchange for payment of a fee
- Caregivers with limited knowledge of the Italian language
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Dementia or mild cognitive impairment
This trial is currently available in Italy.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Dementia is a global public health challenge with a heavy caregiving burden, impacting families, communities, and healthcare systems. It is a priority in healthcare planning, with focus on early diagnosis and ongoing support. This research project addresses the global public health challenge posed by dementia, focusing on early detection and comprehensive care. The research evaluates the clinical, social, and healthcare impact of two dementia-related projects in Italy:
Read full original descriptionShow less
1. the first "Ricor-Dare," aims to create an integrated network for identifying new cases of dementia or Mild Cognitive Impairment (MCI) and providing care to patients and caregivers; 2. the second involves establishing a new Center for Cognitive Disorders and Dementia (CCDD) in an area previously lacking such services.
The primary goal of this study is to assess the effectiveness of case-finding strategies promoted by the "Ricor-Dare" project for the early detection of cognitive decline. Researchers will compare three different settings in which case-finding will be conducted: at the general practitioners' offices, at the Dementia Operations Center, and at Open Days for the general population. The aim is to measure how many individuals in these three settings are diagnosed with Mild Cognitive Impairment (MCI) or dementia, compared to those identified as potential cases through cognitive testing.
The secondary goal of the study is to assess the social, care, and prevention impact of the activities offered within the two projects. This includes evaluating the experiences of patients and families who access the new CCDD in the province of Pavia, the impact of care pathways on caregivers, and comparing the effectiveness of the new CCDD with existing ones in the region of Lombardia. The study will also assess the role of the "Ricor-Dare" project in addressing the needs of patients, caregivers, and professionals, as well as the effectiveness of awareness-raising and training activities on dementia. Overall, the study aims to provide valuable insights into improving care for people with dementia and supporting their families and caregivers.
The group in the trial
- Detection of people reporting cognitive concernsOther group
Treatment: Case-finding for Neurocognitive Disorders
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- OPENING OF A MEMORY CLINIC IN THE PROVINCE OF PAVIA: Evaluation of Case-finding Strategies and Care for People With Cognitive Decline and Their Caregivers.
- Plain-language title
- Finding early memory problems and dementia in different places in PaviaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT06983119, who can take part
- Record updated
- 21 May 2025